Eli Lilly stock drops 2% as traders eye China approval and a late-day CFO readout
New York, March 2, 2026, 14:32 — Trading in the regular session. Eli Lilly and Company shares slipped 2.3% to $1,028.07 in Monday afternoon trading. Earlier in the session, the stock climbed as high as $1,056.84 but also dropped to $1,023.50 at its lowest. The drugmaker now holds a market value near $686 billion.
